4-FA

Current official national law expressly controls 4-FA in United States; unauthorized possession, supply, or manufacture is prohibited.

Australian federal law names 4-FA in the customs import control. Item 96A of Schedule 4 to the Customs (Prohibited Imports) Regulations 1956 is 4-fluoroamphetamine (otherwise known as 4-FA). Schedule 4 is headed Drugs and is made for regulation 5, and the regulation 5(20) definition of a drug takes in any chemical, compound or other substance or thing included in Schedule 4, its isomers, its derivatives, and any substance other than an exempted preparation that contains or consists in part of them. Regulation 5(1) prohibits the importation into Australia of a drug unless the importer holds both a licence to import drugs and a permission to import the drug granted by the Secretary or an authorised person, the permission or a copy of it is produced to the Collector, the drug is imported within the period the permission specifies, and the quantity does not exceed the quantity the permission allows. Regulation 5(2) and regulation 5(2A) set that requirement aside for a drug whose importation the Minister has approved by legislative instrument, and for a drug a passenger on a ship or aircraft carries for the medical treatment of that passenger, of another passenger in the passenger's care, or of an animal being imported in the passenger's care, in each case where a medical practitioner or veterinarian prescribed it and it was supplied in accordance with that prescription. Commonwealth law also reaches conduct inside Australia. Item 117 of the table in clause 1 of Schedule 1 to the Criminal Code Regulations 2019 is 4-Fluoroamphetamine, with a commercial quantity of 0.75 kilograms, a marketable quantity of 250.0 grams and a trafficable quantity of 0.75 grams, and regulation 11 provides that each item of that table lists a substance that is a controlled drug for paragraph 301.1(1)(a) of the Criminal Code. Part 9.1 of the Criminal Code, headed Serious drug offences, then applies to that substance throughout the country: section 300.3 applies extended geographical jurisdiction category B to every offence against the Part, which reaches conduct occurring wholly or partly in Australia, so the offences bind in every State and Territory. Section 308.1(1) makes possession of a controlled drug an offence with a maximum of 2 years imprisonment or 400 penalty units or both. Section 302.4, in Division 302, makes trafficking in a controlled drug an offence carrying 10 years or 2,000 penalty units or both, and section 305.5, in Division 305, makes manufacturing a controlled drug for a commercial purpose an offence carrying 10 years or 2,000 penalty units, or 12 years or 2,400 penalty units where the offence is aggravated. A drug analogue of a listed controlled drug is itself a controlled drug under paragraph 301.1(1)(b). Section 300.4 preserves the concurrent operation of State and Territory law, and section 308.1(3) allows a person charged with the Commonwealth possession offence to be dealt with as if it were the corresponding State or Territory offence, capped at the Commonwealth maximum. The Poisons Standard, which the states and territories implement, does not list the substance. The current instrument, the Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, which commenced on 1 June 2026 and repealed its February 2026 predecessor, lists amfetamine in Schedule 8, headed Controlled drugs, and lists 4-fluoro-N-methylamfetamine in Schedule 9, headed Prohibited substances, without listing 4-fluoroamphetamine anywhere, and its Schedule 9 group entries for amfetamines run only to alkoxyamfetamines, alkylthioamfetamines and substances structurally derived from methoxy-phenylethylamine. The Standard's introduction describes its scheduling classifications as recommendations to Australian States and Territories, and states that the scheduling of poisons is implemented through relevant State and Territory legislation. Queensland is one jurisdiction that names the substance in its own drug schedule. It names 4-Fluoroamphetamine in Schedule 2 of the Drugs Misuse Regulation 1987, and section 4 of the Drugs Misuse Act 1986 makes a thing stated in that Schedule a dangerous drug together with its derivatives, stereo-isomers, salts and analogues. No Schedule 3 quantity is set for it, so in Queensland the maximum penalty is 15 years imprisonment for unlawful possession under section 9, 15 years for unlawful supply under section 6 rising to 20 years or 25 years where the supply is aggravated, 15 years for unlawful production under section 8, and life imprisonment for carrying on the business of unlawfully trafficking under section 5. Supply there includes giving, distributing, selling, administering and transporting, and unlawfully means without authorisation, justification or excuse by law.

The Suchtgiftverordnung names 4-Fluoroamphetamin, 4-FA in Anhang IV.1¹³ and equates the substances captured under Anhang IV.1 with Suchtgifte for the purposes of § 2(2) of the Suchtmittelgesetz.¹³ BGBl. II Nr. 167/2019, issued on 26 June 2019, inserted that line into Anhang IV.1,¹⁴ and § 35(13) of the Suchtgiftverordnung brings the amended annex into force at the end of the day of publication.¹³ Suchtmittelgesetz § 27(1) Z 1 makes the vorschriftswidrig acquisition, possession, production, transport, import, export, offering, transfer or supply of a Suchtgift an offence, subject to the qualifications and penalties of § 27.¹⁵ Neue-Psychoaktive-Substanzen-Gesetz § 2(2) excludes substances and preparations subject to the Suchtmittelgesetz from that Act,¹⁶ and § 1(4) of the Suchtgiftverordnung subjects every substance listed in Anhänge I to V to the Suchtmittelgesetz as a Suchtgift, so 4-FA falls under the Suchtmittelgesetz rather than the Neue-Psychoaktive-Substanzen-Gesetz.¹³¹⁶ Suchtmittelgesetz § 5(1) allows Suchtmittel to be acquired, possessed, produced, processed, transported, imported, exported, offered, transferred or supplied only for medical, dental, veterinary or scientific purposes and only under that Act, and Suchtgiftverordnung § 2 makes the production, processing, conversion, acquisition and possession of Suchtgift conditional on an authorization of the health minister.¹⁵¹³

The current Belgian framework is a national generic structural schedule. AFMPS's current legislation page (last updated 16 July 2026) identifies the 6 September 2017 Royal Decree as the governing instrument and warns that only Official Gazette annexes and amendments have official legal value; its consolidated Annex IV PDF is expressly a non-official aid and says Annex IVa cannot be rendered as a limitative named list. Under Article 6 of the decree, import, export, transport, manufacture, production, possession, sale, offering for sale, supply, delivery and acquisition of listed products require prior activity authorization; that authorization is personal and limited to scientific or medical purposes. Article 21 requires a legally obtained signed and dated medical prescription for pharmacy delivery of medicines to the public and adds address, dose, unit-count, dosage and (where applicable) duration requirements for Annex IV substances; this regulates a medicine-delivery pathway and does not establish an approved 4-FA medicine or ordinary recreational legality. Article 61 applies the Article 2bis drug-law penalties to decree violations (the cannabis-only lower-penalty exceptions do not apply to 4-FA). As of 27 August 2026, the operative pre-reform Article 2bis text provides imprisonment of three months to five years and a EUR 1,000-100,000 fine for ordinary intentional violations, with higher reclusion ranges for specified aggravating circumstances; the 16 March 2026 penalty-reform language is annotated as effective 1 September 2026 and is not treated as current on the access date. Article 63 also requires a physician or dentist who prescribed or obtained products to justify their use when required before the Federal Commission for the Control of Healthcare Practice. 4-FA has no ordinary prescription authorization.

Portaria SVS/MS nº 344/1998 lists 4-FA, also named 4-fluoroanfetamina or 1-(4-fluorofenil)propan-2-amina, in Lista F2 of its Anexo I, the list of psychotropic substances of proscribed use in Brazil.²³ ANVISA added the substance to that list by RDC nº 32 of 30 July 2015, and the annex as updated through RDC nº 1.036 of 9 July 2026 still carries it. Article 4 of the Portaria prohibits the production, manufacture, import, export, trade, and use of proscribed substances, save for bodies and institutions authorized by the health authority strictly for medical and scientific research. Lei nº 11.343/2006 treats the substances on the Portaria SVS/MS nº 344/1998 lists as drugs and prohibits drugs throughout the national territory except under legal or regulatory authorization. Acquiring, keeping, storing, transporting, or carrying 4-FA for personal consumption without authorization attracts a warning, community service, or attendance at an educational programme, the last two for up to five months. Importing, exporting, producing, selling, offering for sale, storing, transporting, or supplying it without authorization is punishable by five to fifteen years of imprisonment and 500 to 1,500 day-fines.

The official Bulgarian List I schedule expressly names 4-FA; the systematic-name parenthesis anomaly appears exactly as printed in the State Gazette. List I is defined as high-risk substances prohibited for application in human and veterinary medicine. Under the Control of Narcotic Substances and Precursors Act, Article 30 prohibits production, processing, trade, storage, import, export, re-export, transit, carrying, transport, offering, acquisition, use and possession of List I plants, narcotic substances and preparations. Article 4(2) applies the same control measures to preparations and analogues. Article 31 and Article 73 preserve only tightly limited, permit-based quantities and activities for medical, scientific, laboratory-research and educational purposes (and service-dog training); these exceptions do not create ordinary medical or prescription access to 4-FA. The latest State Gazette amendment (Decree No. 100/2026, published 14 August 2026) changes specifically enumerated List I rows and does not identify 4-FA as changed; the 4-FA List I entry also appears in the official 2023 List I price schedule. The 4-FA List I classification appears current on 2026-08-27; statutory authorizations mean that not every possible act is unlawful.

Current official national law expressly controls 4-FA in Canada; unauthorized possession, supply, or manufacture is prohibited.

Current official Ley Chile text places the exact identity 1-(4-fluorofenil)propan-2-amina (4-FA) in Article 1 of Decreto 867. Article 1 is the severe-effects category referred to by Article 1 of Law 20.000, not the lower Article 2 category. Law 20.000 Articles 1 and 3 make unauthorized manufacture, trafficking, import, export, transport, acquisition, transfer, possession, supply, keeping or carrying of Article 1 substances criminal; Article 4 provides only a limited small-quantity treatment/personal-exclusive-and-proximate-use justification, not general legalization. Article 6 penalizes a physician, dentist or veterinarian who prescribes an Article 1 substance without medical or therapeutic need. 4-FA has no ordinary prescription pathway. The Decreto 867 consolidated text extends its Article 1 listings to isomers, esters and ethers (unless expressly excepted) and salts (including salts of those forms), but does not establish a blanket rule for every analogue outside those categories.

The official Shenzhen Public Security Bureau current controlled-substance portal expressly places 4-FA in section III, the 2025 non-medical narcotic and psychotropic directory, as entry 18, with the exact Chinese and English chemical names and CAS 459-02-9. Under Article 4 of the current national regulation, non-medical listed substances may be used only for legally compliant experimental research and may not be produced, dealt in, used, stored, or transported; ordinary prescription-only access is not permitted. The 2025 medicinal narcotic and psychotropic schedules are separate directories. The directory notes include salts and stereoisomers (and their salts) unless otherwise specified. The directory's scope includes the listed 4-FA substance and those expressly covered forms, but not unlisted analogues. These controls apply in mainland China as of 27 August 2026.

The current 2023 list superseded the NN 13/19 and 134/21 list on 18 February 2023. The latest official list amendment, NN 154/2024, adds O-PCE and changes precursor entries; it does not amend the amphetamines row. The 2009 official list expressly named parafluoramfetamin / Parafluoroamphetamine as 1-(4-florfenil)propan-2-amin (1-(4-fluorophenyl)propan-2-amine); it identifies 4-FA and records its historical Croatian treatment, but that list is historical and was superseded. The statutory exception is conditional and does not establish that 4-FA is an approved medicine or generally prescription-available; 4-FA has no medicinal product or prescription authorization. Article 190(2)'s current maximum for unauthorized production, processing, import or export is three years after the 2025 amendment.

e-Sbírka identifies Regulation No. 463/2013 Coll. as current from 25 June 2026 and lists 4-Fluoramfetamin / 4-FA / 1-(4-fluorfenyl)propan-2-amin in Annex 4, List 4 psychotropic substances. Act No. 167/1998 Coll. defines psychoactive substances listed in Annexes 1 through 7 of the Government Regulation as addictive substances; its handling definition covers research, manufacture, processing, acquisition, storage, supply, use, purchase and sale. For Annex 4 substances, use is limited to the restricted research, scientific and very limited therapeutic purposes defined in a handling permit, and § 4 generally requires a handling permit. There is no ordinary prescription-medicine route for 4-FA, and the law does not enumerate individual permit holders; unauthorized handling is prohibited, but licensed research or very limited therapeutic activity remains possible. The operative provisions contain no ordinary consumer, recreational or general commercial exception.

Scheduled in the government decree on narcotic substances, preparations, and plants.⁵⁶ Annex II of that decree lists 4-FA as 4-fluoroamphetamine with the systematic name 1-(4-fluorophenyl)propan-2-amine, under the Schedule II heading of the 1971 Psychotropic Convention, and section 1 of the decree makes every substance, preparation, and plant named in Annexes I to V a narcotic. Section 5 of the Narcotics Act prohibits the production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession, and use of a narcotic, and permits departures only for medical, research, control, and industrial purposes as separately provided by law. Section 48 of that Act assigns narcotics offences to Chapter 50 of the Criminal Code, under which unlawful manufacture, import, export, transport, sale, brokering, distribution, possession, or attempted acquisition of a narcotic is a narcotics offence carrying a fine or up to two years' imprisonment, an aggravated narcotics offence carries one to ten years' imprisonment, and unlawful use or possession of a small quantity for personal use is a narcotics user offence carrying a fine or up to six months' imprisonment.

Annexe III of the arrêté du 22 février 1990 fixing the list of substances classified as narcotics names 4-fluoroamphétamine ou 4-FA, and article 1 of that arrêté classifies as narcotics the substances and preparations named in its annexes. Annexe III corresponds to Schedules I and II of the 1971 Convention on Psychotropic Substances and covers the substances it names together with their salts wherever they exist; it extends to stereoisomers only for entries marked with an asterisk, and the 4-FA entry carries none. The arrêté du 14 octobre 2019 placed the substance in Annexe III with effect from 17 October 2019, and Annexe IV, which had named 4-fluoroamphétamine since 17 March 2011, no longer contains it. Article 222-41 of the Penal Code treats substances classified as narcotics in application of article L. 5132-7 of the Public Health Code as narcotics for its trafficking offences, and the list of the arrêté du 22 février 1990 is drawn up in application of that article. Unlawful transport, possession, offering, transfer, acquisition or use of a narcotic carries ten years' imprisonment and a fine of 7 500 000 euros under article 222-37, unlawful production or manufacture carries twenty years' criminal imprisonment and the same fine under article 222-35, and unlawful import or export carries ten years' imprisonment and the same fine under article 222-36. Article L. 3421-1 of the Public Health Code punishes unlawful use of a narcotic with one year's imprisonment and a fine of 3 750 euros, raises those penalties to five years and 75 000 euros where the offence is committed in the exercise or on the occasion of the exercise of their functions by a person vested with public authority or entrusted with a public service mission, or by staff of a road, rail, sea or air undertaking carrying goods or passengers who perform duties bearing on the safety of the transport, the list of those duties being fixed by decree adopted in the Conseil d'État, and permits the base offence to be settled by a fixed fine of 500 euros.

Current official national law expressly controls 4-FA in Germany; unauthorized possession, supply, or manufacture is prohibited.

The 2026.06.29 consolidated National Legislation Database rendition of Decree 78/2022 expressly places 4-FA in Annex 2, P2. The P2 clause extends each listed substance to qualifying stereoisomers and salts where they exist and are not expressly excepted; the annex says the A-C columns control classification, while formula and InChIKey columns are for computer searching. Btk § 459(1a), as established by the 2025 amendment, defines kábítószer for the relevant offenses to include substances in Annex 2 P1/P2, so the P2 listing is legally operative for the drug offenses. Btk §§ 176 and 178 criminalize offering, transfer, distribution, trade, acquisition, possession, import, export and transit of a kábítószer; § 178(6) separately criminalizes consumption and acquiring/possessing a small quantity for consumption. The current Btk threshold is a maximum 1 gram of pure active 4-fluoroamphetamine calculated in base form under § 461(1)(ah), not a lawful possession allowance. Btk § 180 provides a conditional, fact-specific non-punishment route for certain small-quantity own-use conduct only where all statutory conditions are met (including admission, documented six-month treatment/other care/preventive service and disclosure/cooperation); it does not legalize 4-FA. The activity-control decree requires a permit for listed controlled-substance production, manufacture, export, import, transfer, acquisition, distribution, storage, possession, supply, use, research, analysis and related activities, with a separate case-specific export/import permit for import/export. Medical status is limited and conditional: the medicines act defines a P2-P4 active-ingredient medicine as a psychotropic-classified medicine, while the prescription decree allows a doctor to order an authorized medicine or magistral medicine; P2-classified medicines may only be issued on prescription, and a P2 medicine cannot be dispensed against a foreign prescription covered by the foreign-prescription rule. Ordinary unauthorized conduct is prohibited, subject to statutory permits and the narrow § 180 conditions; authorization or a case-specific defense may affect whether a particular act is unlawful.

The current consolidated First Schedule expressly names פלואורואמפטאמין / Fluoroamphetamine, gives FMP as a synonym, and covers the ortho, meta, or para position. WHO identifies 4-FA as 1-(4-fluorophenyl)propan-2-amine, so 4-FA is the para member of the Israeli entry. Under section 1, a dangerous drug includes a substance in the First Schedule and its salts, preparations, compounds, mixtures, solutions, and their salts. Section 7 prohibits possession and use unless permitted by the Ordinance, regulations, or a Director's licence; section 13 similarly prohibits import, export, trade, other transactions, and supply absent a statutory, regulatory, or licensed authorization. The ordinary Personal Import Order expressly does not apply to dangerous drugs under section 7(1), so it does not create a personal-import exemption. The listing is in Part A, not Part B; section 11's specified possession route for drugs in Part B therefore is not an ordinary prescription classification for 4-FA. The current consolidated entry bears amendment references to Gazette amendments from 2008 and 2010, and the 2025 First-Schedule notice adds other substances without replacing this entry. Unauthorized possession, use, and commerce are prohibited, subject to any authorization expressly available under Israeli law.

Article 1 of the decree expressly inserts 4 Fluoroamfetamina in Tabella I and gives the chemical designation ((RS)-1-(4-fluorofenil)propan-2-amina) and other denomination 4-FA; the decree entered into force on the fifteenth day after publication (27 November 2012). The decree's rationale identifies 4-Fluoroamfetamina as an amphetamine analogue and central-nervous-system stimulant. Normattiva's current-date page confirms that the governing D.P.R. 309/1990 remains in force at 27 August 2026 and was last updated 6 August 2026; a 28 April 2026 Ministry update confirms that Table I remains an actively maintained schedule under that decree. 4-Fluoroamfetamina is prohibited as a Table I scheduling classification, not prescription-only status. Article 73 is the applicable enforcement framework for unauthorized conduct involving Table I substances, while personal-use facts can engage separate provisions. Personal-use administrative treatment, research authorization, medical supply, penalties under each temporal version, and coverage of particular preparations depend on provisions beyond the Table I classification.

4-FA appears by name on lijst I of the Opiumwet (Dutch Opium Act), where the row gives the other name 4-FA and the further description 4-fluoramfetamine. The Besluit of 11 May 2017 (Staatsblad 2017, 206) inserted that row, and under its article II the decree took effect the day after the Staatsblad was issued on 24 May 2017, so the listing has applied since 25 May 2017. The consolidated Opiumwet in force from 9 July 2026 still carries the row. The placement rests on article 3a, second paragraph, which allows a substance to be added to lijst I where it affects human consciousness and its use can harm the user's health and society, and not on a treaty obligation. Article 2 forbids bringing a lijst I substance into or out of Dutch territory, cultivating, preparing, treating, processing, selling, delivering, supplying or transporting it, possessing it, or manufacturing it, and article 1, second paragraph, equates the salts of a listed substance with the substance itself. Article 10 sets the penalties: contravening article 2 carries up to six months' detention or a fourth-category fine; intentional possession carries up to six years' imprisonment or a fifth-category fine; intentional cultivation, preparation, sale, supply, transport or manufacture carries up to eight years; and intentional import or export carries up to twelve years. Where intentional possession or intentional import or export concerns a small quantity intended for personal use, the maximum falls to one year's imprisonment or a third-category fine. A lijst I substance may be prescribed only if it has been designated for prescription by decree under article 4, first paragraph. The Minister of Health, Welfare and Sport may grant an exemption from the article 2 prohibitions under article 6, on the article 8 grounds of public or animal health, scientific or analytical-chemical research, instruction, a contract with another exemption holder or a dispensing professional, or industrial production. Use of 4-FA rose in the years before the listing, and the explanatory note to Staatsblad 2017, 206 names that rise, the accompanying increase in health incidents, and the substance's ready availability while it stood outside the Opiumwet as the grounds for placing it on lijst I.

Controlled as a Class C substance under the Misuse of Drugs Act due to classification as an amphetamine analogue.⁸⁸ 4-FA is not specified or described in Schedule 1, Schedule 2, or Parts 1 to 6 of Schedule 3, and reaches Class C through the controlled drug analogue limb of the section 2(1) definition: its structure is substantially similar to that of amphetamine, a Class B controlled drug, and it answers the Part 7 of Schedule 3 description of amphetamine analogues in which the 1-amino-2-phenylethane nucleus carries a methyl radical attached to the carbon atom adjacent to the nitrogen atom together with a halogen radical attached to the benzene ring.⁸⁸ Unless authorised by a licence, by regulations, or by the Act's own exemptions, procuring, possessing, consuming, or otherwise using it is an offence carrying up to 3 months imprisonment or a fine of up to $500, and a custodial sentence for an offence relating only to a Class C controlled drug requires previous convictions or exceptional circumstances.⁸⁸ Importing, exporting, producing, or manufacturing it carries up to 8 years imprisonment, as do selling or offering to sell it to a person of or over 18, supplying or administering it to a person under 18, and possessing it for either of those sale or supply purposes; supplying or administering it to a person of or over 18 otherwise than by sale carries the same 3 months imprisonment or $500 fine as procuring, possessing, or using it.⁸⁸ Possessing a controlled drug analogue for a purpose other than pharmacological use or supply to another person is a statutory defence.⁸⁸

Poland lists 4-FA as 4-FLUOROAMFETAMINA at item 42 of Group II-P in Annex 1 to the Regulation of the Minister of Health of 17 August 2018 on the list of psychotropic substances, narcotic drugs and new psychoactive substances, alongside the abbreviations 4-FMP and 4-FA and the chemical designation 1-(4-fluorofenylo)-2-aminopropan.⁸⁹ Since the consolidated text of that Regulation announced on 17 June 2024, the Annex has been amended twice, by Dz.U. 2025 poz. 598 and Dz.U. 2026 poz. 934, and neither amendment touches item 42.⁹⁰⁹¹⁹² Article 32 of the Act of 29 July 2005 on Counteracting Drug Addiction divides psychotropic substances into Groups I-P to IV-P, and Article 33(1) permits Group II-P substances to be used only for medical, industrial or research purposes.⁹³ Article 34(1) reserves possession of a psychotropic substance to an undertaking, organizational unit or natural person authorized to hold it under the Act.⁹³ Possession contrary to the Act is punishable under Article 62(1) with imprisonment of up to three years.⁹³ The Act's consolidated text of 17 August 2023 has since been amended only by the Act of 3 July 2026, which leaves Articles 32, 33, 34 and 62 as they stand.⁹⁴⁹⁵

4-FA appears in the current Serbian schedule⁹⁶, and the 2026 rule supersedes the 2024 list.⁹⁶ The listing stands at item 20 of Lista 5, which gives the name 4-F-amphetamine, the systematic name 1-(4-fluorophenyl)propan-2-amine and CAS number 459-02-9.⁹⁶ Lista 5 holds psychotropic substances used for limited therapeutic and scientific-research purposes, in accordance with Schedule 2 of the Convention on Psychotropic Substances.⁹⁷ The Zakon o psihoaktivnim kontrolisanim supstancama forbids the production, trade, use and supply of psychoactive controlled substances except under the conditions it prescribes, counts possession of such a substance contrary to its provisions as illicit production and trade, and applies the rules governing criminal offences to that conduct.⁹⁷ A legal person that produces or trades in a psychoactive controlled substance contrary to that prohibition is fined 1,000,000 to 3,000,000 dinars for an economic offence and the responsible person within it 100,000 to 200,000 dinars, and an individual who supplies such a substance is fined 40,000 to 50,000 dinars for a misdemeanour.⁹⁷

Annex 1 to Act No. 139/1998 Coll. lists 4-FA by name among the psychotropic substances of Group I, as "4-FA, 4-Fluóramfetamín, chemicky (RS)-1-(4-fluórfenyl) propán-2-amín", and that listing stands in the consolidated text effective from 1 January 2026.⁹⁸ Section 4(1) of that Act allows a natural or legal person to handle narcotic and psychotropic substances only under a permit issued by the Ministry of Health of the Slovak Republic and only where the conditions the Act lays down are met, and section 4(3) allows substances of Group I to be cultivated, produced, imported, exported, dispensed, transited and distributed wholesale only for research, teaching and expert activity.⁹⁸ Handling in any manner other than the Act provides is unlawful handling under section 4(4).⁹⁸ Unauthorised possession of a psychotropic substance other than cannabis, cannabis resin or a substance containing tetrahydrocannabinol carries up to two years of imprisonment in a negligible amount under section 171(2) of the Criminal Code and six months to three years in a small amount under section 171(3), rising to one to six years for a larger amount or for a conviction for the same act in the preceding twenty-four months under section 171(4); unauthorised production of or trade in a psychotropic substance in a negligible amount carries one to five years under section 173(1).⁹⁹

South Korea lists 4-FA as item 40 of Appendix 3 to the Enforcement Decree of the Act on the Control of Narcotics, etc., under the name 4-플루오로암페타민 (4-Fluoroamphetamine, 4-FA) with the chemical name 1-(4-fluorophenyl)-2-propanamine,¹⁰⁰ and that appendix extends to the salts, isomers and salts of isomers of every substance it lists.¹⁰⁰ Article 2(3) of the Enforcement Decree assigns the psychotropic substances falling under Article 2, subparagraph 3, item (a) of the Act to Appendix 3.¹⁰² Article 3, subparagraph 5 of the Act forbids any person to possess, own, use, manage, import, export, manufacture or sell such a substance, to induce, solicit or broker its sale, or to transfer or receive it, unless the Minister of Food and Drug Safety grants approval as prescribed by Presidential Decree.¹⁰¹ Article 3(2) of the Enforcement Decree limits that approval to research by an academic researcher licensed to handle narcotics, handling required by official duty, test use by a licensed narcotics manufacturer, purchase brokerage by a trader under the Foreign Trade Act that issues an offer to sell, and comparable cases the Minister of Food and Drug Safety recognizes.¹⁰² Manufacture, import, export, sale, inducement, solicitation or brokerage of a sale, transfer or receipt, and possession or ownership for any of those purposes carry imprisonment for life or for at least five years under Article 58(1)3 of the Act, and death, imprisonment for life or imprisonment for at least ten years under Article 58(2) where the act is committed for profit or habitually.¹⁰¹ Possession, ownership, use or management of the substance carries limited-term imprisonment of at least one year under Article 59(1)5.¹⁰¹ Use of the substance otherwise than under the Act, and the provision to another person of premises, facilities, equipment, funds or means of transport for a prohibited act involving it, carry imprisonment for up to ten years or a fine of up to 100 million won under Article 60(1)1.¹⁰¹

4-FA is narkotika in Sweden.¹⁰³¹⁰⁴ Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika, in the consolidated text carrying amendments through HSLF-FS 2026:26, place 4-fluoroamfetamin, also named 4-fluoramfetamin and 4-FA and given the chemical name 1-(4-fluorofenyl)propan-2-amin, in Swedish förteckning I and mark it as a psychotropic substance under Schedule II of the 1971 psychotropic convention.¹⁰³ Förteckning I covers substances, plant material and fungi that normally have no medical use.¹⁰³ 4-fluoramfetamin also stands among the central stimulants in bilaga 1 to förordningen (1992:1554) om kontroll av narkotika, and 2 § of that förordning provides that the substances in bilaga 1 count as narkotika under narkotikastrafflagen (1968:64).¹⁰⁴ Unlawful transfer, production for misuse, acquisition for the purpose of transfer, handling not intended for own use, possession, use and other dealing with narkotika are narkotikabrott under 1 § narkotikastrafflagen, punishable by imprisonment for up to three years, and by six months to three years where the offender sells narkotika or otherwise handles narkotika intended for sale.¹⁰⁵ A ringa narkotikabrott carries a fine or imprisonment for up to six months, a grovt narkotikabrott two to seven years, and a synnerligen grovt narkotikabrott six to ten years.¹⁰⁵ Unlawful import and export are punished under lagen (2000:1225) om straff för smuggling.¹⁰⁵

The authoritative Swiss schedule expressly lists 4-Fluoroamphetamin (4-FA) and 1-(4-Fluorophenyl)propan-2-amin under the d designation in Annex 5 (Verzeichnis d), with GTIN 7611746991052. BetmKV defines Verzeichnis d as prohibited controlled substances. The substance is prohibited rather than ordinarily available by prescription or pharmacy dispensing: the schedule does not itself create a medical authorization, and applicable rules provide only permit and exception routes. Unauthorized possession, custody, acquisition, production, import/export, sale or other handling can trigger BetmG controls and offences; licensed handling and statutory BAG exceptions remain relevant. BetmVV-EDI Article 1(2) extends control to the listed substance's specified salts, esters, ethers, carbamates, stereoisomers, certain derivatives of those stereoisomers and preparations containing covered substances; the rules do not establish a broad rule for unrelated analogues. Swissmedic says its supplementary lists are not exhaustive and that only the BetmVV-EDI schedules are binding.

The Turkish National Police Narkotics archive's Turkish EMCDDA report identifies 4-FA as '4-FA (4-floroamfetamin)'. The current Justice Ministry consolidated Penal Code text criminalizes unlicensed manufacture, import/export, domestic sale, offering, giving, dispatch, transport, storage, purchase, acceptance and possession of uyuşturucu veya uyarıcı maddeler in Article 188(1) and (3). Article 188(4)(a) expressly includes 'amfetamin ve türevleri' and raises the penalty by one half; Law No. 7445 Article 17 inserted that phrase, effective on publication on 5 April 2023. Article 191(1) separately criminalizes purchasing, accepting, possessing for use, or using a narcotic or stimulant substance. Article 188(6) extends the preceding rules to any substance producing a narcotic or stimulant effect whose production requires official authorization or whose sale requires an authorized doctor's prescription. No separate approved-medicine or ordinary prescription route for raw 4-FA is established. No current Turkish schedule row names 4-FA verbatim; the applicable classification is the statutory amphetamine-derivative category, and the 2011 named-substance decision does not expressly list 4-FA. Application to a particular sample remains dependent on forensic identity and the facts of the conduct, and lawful authorization or case-specific statutory treatment provisions are not ruled out.

Current official national law expressly controls 4-FA in United Kingdom; unauthorized possession, supply, or manufacture is prohibited.